October 27, 2014 – Verastem, Inc. recently presented new information on its stem cell research at the 12th International Mesothelioma Interest Group Conference in Cape Town, South Africa on October 21st – 24th. The presenters focused on developments in the lead inhibitor VS-6063, known as defactinib, which is proving to be effective at targeting mesothelioma […]
October 15, 2014 – A new multi-million dollar study will be conducted in a local town well-known for large amounts of asbestos waste. University of Pennsylvania’s Center of Excellence in Environmental Toxicology was awarded a $10 million federal grant to determine exactly how people are exposed to asbestos. Specifically, the study will focus on concerns […]
October 8, 2014 – Italian and Swedish researchers recently reported new information in the treatment of mesothelioma, which is an aggressive form of cancer resulting from exposure to asbestos. By using the KB9520 molecule to activate the Estrogen Receptor Beta (ERbeta) found in the nucleus of cells, researchers discovered that mesothelioma tumor cell growth slowed […]
October 3, 2014 – A recent article entitled “Asbestos: The Killer That Still Surrounds Us” provides an important reminder that individuals exposed to asbestos in the past may still be at risk for developing the fatal disease of mesothelioma. Published in the London Telegraph, the article discusses the continued diagnosis of new mesothelioma cases despite […]
October 2, 2014 – Students in the East Penn School District in Lehigh County, Pennsylvania may potentially be exposed to toxic asbestos in the near future. There are plans underway to remove industrial debris containing asbestos in close proximity to Wescosville Elementary School located in Lower Macungie Township. It is important that asbestos removal takes […]
September 30, 2014 – Philadelphia mesothelioma lawyers, Ben Shein and Bethann Kagan, of the Shein Law attended the sixth annual Focus on Mesothelioma Conference hosted by University of Pennsylvania’s Abramson Cancer Center and the Mesothelioma Applied Research Foundation (MARF.) The conference was held on September 24, 2014 in recognition of National Mesothelioma Awareness Day. The Abramson […]
September 24, 2014 – Ben Shein of the Shein Law is one of the leading sponsors for the upcoming Ride to Conquer Cancer®, benefiting Penn Medicine’s Abramson Cancer Center. The 2014 Structure Tone Ride to Conquer Cancer® is a two day event to be held on October 11-12th. Participants will bike ride throughout Pennsylvania to […]
September 18, 2014 – Researchers at the Juntendo University School of Medicine in Tokyo recently reported that a study involving a new blood test is showing promising results for diagnosing mesothelioma in its early stages. The blood test identifies N-ERC/mesothelin, which is a protein biomarker that is elevated in patients with mesothelioma. With a 95% […]
September 16, 2014 – Researchers at the University of Pennsylvania recently reported successful outcomes for lung cancer patients undergoing surgery to remove cancerous tumors and tissue. They found that patients are less likely to experience a local recurrence of their cancer following surgery when using a technique involving near-infrared imaging (NIR) and a contrast dye […]
September 11, 2014 – It is well-known that prolonged direct exposure to asbestos is a risk factor for developing mesothelioma; however, a new case study suggests that even indirect or minimal exposure to a lesser amount of asbestos for a short time can also increase the risk of developing mesothelioma. In New Delhi, India, Dr. […]
